By Heidi Ledford
By looking for the genetic alterations that occur in tumour cells, a new assay could allow clinicians to use a simple blood test to track cancer during and after treatment.
The technique, developed by Victor Velculescu and Rebecca Leary at Johns Hopkins Kimmel Cancer Center in Baltimore, Maryland, and their colleagues, generates patient-specific biomarkers using high-throughput DNA sequencing. [More]
If you found this reporting useful, please consider supporting our work with a small donation. Your contribution lets us continue to bring you accurate, thought-provoking science and medical news that you can trust. Independent reporting takes time, effort, and resources, and your support makes it possible for us to keep exploring the stories that matter to you. Thank you so much!